Mesothelioma

5 trials MedDRA PT
5 Registered trials
0 Recruiting
5 Unique sponsors
2 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 4
V Various (ATC V) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase I/II: 1 Phase IV: 1 Phase I: 2 Phase I (Other): 1

Filter these 5 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 5 trials

Phase I/II

1 trial

Phase IV

1 trial
  • Amphia Hospital Academic
    CALCIUM FOLINATE
    2022-502345-10-00 1 country 2023 n=50
    Ended

Phase I

2 trials
  • Amgen Inc. Commercial
    IMP not specified
    2022-502867-39-00 3 countries 2023 n=58
    Ended
  • Beigene Ltd. Commercial
    IMP not specified
    2023-503996-38-00 1 country 2025 n=60
    Ended

Phase I (Other)

1 trial
  • Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l. Academic
    IMP not specified
    2023-508756-19-00 1 country 2019 n=18
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Amgen Inc. Commercial 1 Phase I 0
Beigene Ltd. Commercial 1 Phase I 0
Epizyme Inc. Commercial 1 Phase I/II 0
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l. Academic 1 Phase I (Other) 0
Amphia Hospital Academic 1 Phase IV 0
New trials by year
2019
1
2023
2
2025
1
← All indication landscapes